Download

    Institut für Virologie und Immunologie (Institute of Virology and Immunology)

    [Declared in accordance with Form A Part 2(iii)]

    2. Responsible public or private organization or company: 
    Federal Food Safety and Veterinary Office, Federal Department of Home Affairs
    3. Location and postal address
    Institut für Virologie und Immunologie, Bundesamt für Lebensmittelsicherheit und Veterinärwesen, Eidgenössisches Departement des Innern, Sensemattstrasse 293, CH-3147 Mittelhäusern, Switzerland
    4. Source(s) of financing of the reported activity, including indication if the activity is wholly or partly financed by the Ministry of Defence

    Swiss Confederation (Federal Department of Home Affairs)

    5. Number of maximum containment units5 within the research centre and/or laboratory, with an indication of their respective size (SqM):
    ABL 3 Ag , 10.446.00 SqM
    Of note, BSL3Ag facilities have special features not comparable to standard BSL3 or BSL4 facilities. The shell is considered BSL4, whereas inside the containment area BSL1, BSL2 and BSL3 space is common standard. Personnel enters through a shower barrier and is provided with suitable laboratory clothing for BSL1, 2 and 3 inside the containment area. Personnel has to shower out when leaving the containment area and has to keep a 72h quarantine (no contact to cloven hoofed animals). The IVI fulfills the requirements of the EU Minimum Biorisk Management Standards for Laboratories Working with Foot-And-Mouth Disease Virus. Due to these special features of BSL3Ag facilities, the BSL3Ag area is not limited to laboratory units only, but also includes engineering floors such as effluent treatment plant or ventilation units and animal units, which are all located within the containment area. Therefore, all maintenance work has to be done during operation – the facility has never been shut down so far. This also means that a direct comparison with BSL4 facilities is not practicable. Licenses are as follows: “Quality controls of immuno-biological products for use in applications of veterinary medicine”; “Establishment of a cell-based rapid test to determine protection provided by vaccination against foot-and-mouth disease virus”; “Validation of decontamination by H2O2”; “Diagnostics of viral pathogens causing highly contagious animal diseases“; “Peste des petits ruminants virulence“.
    BL 3 , 44.00 SqM
    BL 2 , 210.00 SqM
    6. Scope and general description of activities, including type(s) of micro-organisms and/or toxins as appropriate

    The Institute of Virology and Immunology (IVI), which is part of the Swiss Federal Food Safety and Veterinary Office, is the ISO 17025 accredited institute for the diagnosis, surveillance and control of highly contagious epizootics. In addition, the IVI pursues research both on these viruses and emerging viral diseases, as well as their potential transmission to man. The IVI is also the competent authority issuing the licenses required for the sale of veterinary immunobiological products. Basic research is carried out in the fields of immunology and virology, and involves influenza virus, foot-and-mouth disease virus, classical swine fever virus and porcine circovirus type 2, as well as coronaviruses. The development and diagnostics branches focus on assays and tests for classical and african swine fever, foot-and-mouth disease, avian influenza, bluetongue, and other highly contagious infectious diseases. In this domain, the IVI occupies a leading position internationally.

    For further information please visit:
    https://www.ivi.admin.ch/ivi/en/home.html

    (4) For facilities with maximum containment units participating in the national biological defence research and development programme, please fill in name of facility and mark "Declared in accordance with Form A, part 2 (iii)".

    (5) In accordance with the latest edition of the WHO Laboratory Biosafety Manual, or equivalent.

    Report Index